John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$230M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$207M |
| 3 |
EA
Electronic Arts
EA
|
+$205M |
| 4 |
Starbucks
SBUX
|
+$171M |
| 5 |
Baidu
BIDU
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$185M |
| 2 |
Elevance Health
ELV
|
+$180M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$169M |
| 4 |
Walt Disney
DIS
|
+$168M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$166M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.51% |
| 2 | Technology | 14.81% |
| 3 | Industrials | 12.21% |
| 4 | Healthcare | 10.11% |
| 5 | Financials | 6.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENZ
2351
DELISTED
Enzo Biochem, Inc.
ENZ
| $349K | ﹤0.01% |
125,562
+17,823
| +17% | +$58.4K |
|
2352
PUT
United Therapeutics
UTHR
$22.2B
| $348K | ﹤0.01% |
3,200
-2,800
| -47% | -$325K |
|
|
GTLS
2353
DELISTED
Chart Industries
GTLS
| $347K | ﹤0.01% |
5,330
-34,067
| -86% | -$2.25M |
|
2354
PUT
Intercontinental Exchange
ICE
$90.8B
| $347K | ﹤0.01% |
+4,600
| New | +$353K |
|
2355
Icon
ICLR
$13B
| $347K | ﹤0.01% |
+2,682
| New | +$370K |
|
2356
CALL
TAL Education Group
TAL
$6.43B
| $347K | ﹤0.01% |
13,000
-23,100
| -64% | -$613K |
|
|
GOL
2357
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $347K | ﹤0.01% |
+25,615
| New | +$259K |
|
|
ARR
2358
Armour Residential REIT
ARR
$2.32B
| $346K | ﹤0.01% |
3,379
-14,259
| -81% | -$1.54M |
|
2359
PUT
Centene
CNC
$32.1B
| $346K | ﹤0.01% |
+6,000
| New | +$402K |
|
2360
CALL
Olin
OLN
$1.98B
| $346K | ﹤0.01% |
17,200
+9,200
| +115% | +$196K |
|
|
CO
2361
DELISTED
Global Cord Blood Corporation
CO
| $346K | ﹤0.01% |
53,632
-32,763
| -38% | -$209K |
|
2362
Celldex Therapeutics
CLDX
$3.24B
| $345K | ﹤0.01% |
116,072
+1,724
| +2% | +$8.47K |
|
|
ACGN
2363
DELISTED
Aceragen Inc
ACGN
| $345K | ﹤0.01% |
7,337
+6,482
| +758% | +$745K |
|
2364
CALL
Home Depot
HD
$337B
| $344K | ﹤0.01% |
2,000
-56,800
| -97% | -$10.2M |
|
|
STKL
2365
DELISTED
SunOpta
STKL
| $344K | ﹤0.01% |
+88,941
| New | +$506K |
|
2366
The RMR Group
RMR
$336M
| $343K | ﹤0.01% |
6,458
+3,469
| +116% | +$245K |
|
2367
Ceco Environmental
CECO
$4.12B
| $342K | ﹤0.01% |
50,628
-54,333
| -52% | -$416K |
|
2368
Stellus Capital Investment Corp
SCM
$247M
| $341K | ﹤0.01% |
26,334
+5,708
| +28% | +$74.4K |
|
|
DERM
2369
DELISTED
Dermira, Inc.
DERM
| $340K | ﹤0.01% |
47,261
-247,394
| -84% | -$2.71M |
|
2370
PUT
Camping World
CWH
$669M
| $338K | ﹤0.01% |
29,500
+12,900
| +78% | +$229K |
|
2371
CALL
Dillards
DDS
$9.95B
| $338K | ﹤0.01% |
5,600
-9,000
| -62% | -$619K |
|
2372
Pixelworks
PXLW
$42.8M
| $338K | ﹤0.01% |
+9,714
| New | +$452K |
|
|
NXTM
2373
DELISTED
NxStage Medical Inc.
NXTM
| $338K | ﹤0.01% |
11,796
-4,219
| -26% | -$120K |
|
2374
CALL
Agilent Technologies
A
$43.7B
| $337K | ﹤0.01% |
5,000
-6,800
| -58% | -$457K |
|
2375
Assembly Biosciences
ASMB
$719M
| $336K | ﹤0.01% |
+1,238
| New | +$358K |
|
Similar funds
John Overdeck's Q4 2018 Portfolio in Review
As of Q4 2018, John Overdeck held 3,851 positions worth $25.5B, down 30% from $36.7B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
John Overdeck withdrew a net $5.25B in Q4 2018, closing 943 positions and reducing 1,216 holdings. Its most notable exit was Elevance Health, an estimated $180M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.
Against the trend, John Overdeck opened a new position in Starbucks worth $176M.
- John Overdeck's largest Q4 2018 buy was Starbucks: 2,727,875 shares worth $176M.
- John Overdeck added most to SLB Ltd in Q4 2018, an estimated $230M increase.
- John Overdeck's biggest Q4 2018 reduction was Procter & Gamble, cutting an estimated $185M.
- John Overdeck fully exited Elevance Health in Q4 2018, selling an estimated $180M.
- John Overdeck's ten largest holdings make up 6.8% of its $25.5B portfolio in Q4 2018.
- John Overdeck opened 729 new positions and closed 943 in Q4 2018.
- John Overdeck's portfolio value fell 30% quarter-over-quarter to $25.5B.
Based on Two Sigma Investments's 13F filing for Q4 2018, filed 14 Feb 2019.